Publications by authors named "Anastasia A Beloglazkina"

Photoinduced cascade of two 6π-electron six- and five-center electrocyclizations in aromatic azido imines is oxidatively controlled to yield complex fused benzimidazoles or indazoles. Formation of benzimidazoles occurs via an unprecedented carbon-to-nitrogen -iminoaryl 1,2-shift.

View Article and Find Full Text PDF

Novel variously substituted thiohydantoin-based -indolinones were prepared using a regio- and diastereoselective synthetic route from 5-arylidene-2-thiohydantoins, isatines, and sarcosine. The obtained molecules were subsequently evaluated in vitro against the cancer cell lines LNCaP, PC3, HCT, and HCT. Several compounds demonstrated a relatively high cytotoxic activity vs.

View Article and Find Full Text PDF

The YEATS domain has been identified as a reader of histone acylation and more recently emerged as a promising anti-cancer therapeutic target. Here, we detail the structural mechanisms for π-π-π stacking involving the YEATS domains of yeast Taf14 and human AF9 and acylated histone H3 peptides and explore DNA-binding activities of these domains. Taf14-YEATS selects for crotonyllysine, forming π stacking with both the crotonyl amide and the alkene moiety, whereas AF9-YEATS exhibits comparable affinities to saturated and unsaturated acyllysines, engaging them through π stacking with the acyl amide.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Anastasia A Beloglazkina"

  • Anastasia A Beloglazkina's recent research primarily focuses on the synthesis and biological evaluation of novel compounds, particularly in the fields of organic synthesis and cancer therapeutics.
  • Her work includes the development of complex fused benzimidazoles and indazoles through a photoinduced oxidative control mechanism, demonstrating innovative synthetic approaches.
  • Additionally, she has investigated the structural mechanisms of the YEATS domain, highlighting its role in histone acylation and potential as a target for anti-cancer therapies, establishing a connection between structural biology and therapeutic applications.